^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Labcorp® Plasma Focus™

Company:
LabCorp
Type:
Laboratory Developed Test
Related tests:
Evidence

News

7ms
Real-World Evidence Demonstrating the Clinical Performance and Utility of the Labcorp® Plasma Focus™ Liquid Biopsy Test (AMP 2023)
Based on this clinical performance and utility real-world dataset, these data suggest that the Labcorp Plasma Focus test is highly effective for the rapid detection and reporting of clinically actionable and relevant biomarkers to help inform precision oncology decision-making.
Real-world evidence • HEOR • Clinical • Liquid biopsy • Real-world • Biopsy
|
MSI (Microsatellite instability)
|
Labcorp® Plasma Focus™
12ms
Labcorp Plasma Focus™ liquid biopsy test now available (LabCorp Press Release)
"Labcorp...has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for patients with advanced or metastatic solid tumors. The test allows treating oncologists to evaluate circulating cell-free DNA (cfDNA) released by tumor cells and better manage the care of their patients through a personalized, targeted therapy plan."
Launch
|
Labcorp® Plasma Focus™
1year
Liquid biopsy-informed precision oncology study to evaluate utility of plasma genomic profiling for therapy selection. (ASCO 2023)
Patient accrual for this study initiated in February 2023. Clinical trial information: NCT05585684.
Liquid biopsy • Biopsy
|
Labcorp® Plasma Focus™
1year
Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-free DNA Genomic Profiling of Solid Tumors. (PubMed, J Mol Diagn)
Average positive agreement from precision, reproducibility and repeatability experiments was 97.5% and 88.9% for SNVs/indels and CNAs, respectively, and 100% for translocations and MSI. Taken together, these data demonstrate that the Labcorp Plasma Focus test is a highly accurate, sensitive, and specific approach for cfDNA genomic profiling to supplement tissue testing and inform treatment decisions.
Journal
|
MSI (Microsatellite instability)
|
Labcorp® Plasma Focus™
1year
Labcorp® Plasma Focus™: Launch in Q4 2022 (Refinitive StreetEvents)
Q4 2022 Laboratory Corporation of America Holdings Earnings Call
Launch
|
Labcorp® Plasma Focus™